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Background: There is considerable interest in using cell sheets for the treatment of various lesions as part of
regenerative medicine therapy. Cell sheets can be prepared in temperature-responsive culture dishes and applied
to injured tissue. For example, cartilage-derived cell sheets are currently under preclinical testing for use in
treatment of knee cartilage injuries. The additional use of cryopreservation technology could increase the range and
practicality of cell sheet therapies. To date, however, cryopreservation of cell sheets has proved impractical.
Results: Here we have developed a novel and effective method for cryopreserving fragile chondrocyte sheets. We
modified the vitrification method previously developed for cryopreservation of mammalian embryos to vitrify a cell
sheet through use of a minimum volume of vitrification solution containing 20% dimethyl sulfoxide, 20% ethylene
glycol, 0.5 M sucrose, and 10% carboxylated poly-L-lysine. The principal feature of our method is the coating of the
cell sheet with a viscous vitrification solution containing permeable and non-permeable cryoprotectants prior to
vitrification in liquid nitrogen vapor. This method prevented fracturing of the fragile cell sheet even after vitrification
and rewarming. Both the macro- and microstructures of the vitrified cell sheets were maintained without damage
or loss of major components. Cell survival in the vitrified sheets was comparable to that in non-vitrified samples.
Conclusions: We have shown here that it is feasible to vitrify chondrocyte cell sheets and that these sheets retain
their normal characteristics upon thawing. The availability of a practical cryopreservation method should make a
significant contribution to the effectiveness and range of applications of cell sheet therapy.
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The use of cell sheets is being actively investigated in the
field of regenerative medicine as a potential treatment for
various lesions [1,2]. For example, Okano et al. developed
a method of preparing various types of cell sheets using
temperature-responsive culture dishes [3]; additionally,
cell sheets derived from corneal epithelia [4], skin [5], oral
mucosal epithelia [6], bladder epithelia [7], myocardial
cells [8,9], periodontal ligaments [10], and cartilage [11,12]
are currently under investigation in preclinical studies or
clinical applications [13-15].* Correspondence: hnagas@isc.meiji.ac.jp
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reproduction in any medium, provided the orWe have been investigating the use of chondrocyte-
derived cell sheets for treatment of knee cartilage injuries
[11,12,16-18]. Cell sheets can be used as autografts or
allografts. In a clinical setting, the preparation of autologous
cell sheets involves a defined period of time for culture of
the cells. Thus, the timing of transplantation has to be
arranged with regard to both the needs of the patient and
the condition of the cultured cell sheet. Cryopreservation
of cell sheets would simplify the coordination of transplant-
ation timing and would also allow repeated treatments
for a single patient. In addition, development of robust
cryopreservation methods and distribution protocols would
need to be established to facilitate allograft-based cell sheet
therapy. There is little doubt that cryopreservation of
cell sheets would provide significant benefits to clinical
applications of cell sheet therapies.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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membranous sheet [11,19,20]. Therefore, an indispensable
prerequisite of a cryopreservation method is to maintain
the integrity of the membranous structure of the cell sheet.
However, achieving this has been challenging and although
the viability of the cells comprising the sheets can be
maintained, damage to the integrity of the sheet often
occurs [21]. To date, no practical cryopreservation
method has been developed for cell sheets that have been
generated in temperature-responsive culture dishes.
Recent developments in vitrification methods have
allowed practical cryopreservation of early stage embryos
of many mammalian species, including humans [22,23].
Embryos are highly susceptible to damage by various
aspects of cryopreservation, including the toxicity of the
cryoprotectant (CPA), osmotic shock, and temperature
shock [23,24], which makes their successful cryopreserva-
tion more difficult compared to somatic cells. Furthermore,
embryos of some mammalian species such as pigs [25-28]
are especially sensitive to low temperatures. However,
the latest vitrification methods have enabled very high post-
cryopreservation survival rates for mammalian embryos
of a wide range of species, derivations or backgrounds
[23,29,30]. The basic principle of the latest high-perform-
ance method involves vitrifying embryos with a very small
amount of vitrification solution, a process termed the
minimum volume cooling (MVC)-vitrification method
[29-32]. The MVC-vitrification method is effective at
stabilizing the vitreous status of the solution during
vitrification and rewarming, and thereby achieves a high
rate of survival of embryos.
In light of the success achieved in embryos, we decided
to apply the basic principles of the MVC-vitrification
method for cryopreservation of chondrocyte sheets. We
successfully developed a coating method by which a
cell sheet could be vitrified using a minimum amount
of solution. This report describes the development of
an effective vitrification method that does not impair
either the macro- or microstructures of cell sheets, and
thereby possesses significant potential for applications
related to clinical cell sheet therapy.
Methods
Chemicals
All chemicals were purchased from Sigma-Aldrich
Chemical Co. (MO, USA), unless otherwise indicated.
Preparation of rabbit chondrocyte sheets
The study was conducted using commercially available
primary cultured cells (Primary Cell, Hokkaido, Japan)
derived from the knee cartilage of a Japanese white rabbit.
The cells were plated onto temperature-responsive culture
dishes (UpCell, diameter: 35 mm; CellSeed, Tokyo, Japan)
[3] at a density of 5.0 × 104 to 1.0 × 105 cells/dish andcultured in RPMI-1640 medium (11875; GIBCO, Life
Technologies Corporation, CA, USA) supplemented with
10% fetal bovine serum (FBS; 171012, Nichirei Biosciences,
Tokyo, Japan) at 37°C in a humidified atmosphere of 5%
CO2 in air. The medium in each dish was replaced with
the same medium supplemented with 100 μM L-ascorbic
acid (A4544; Wako Pure Chemical Industries, Osaka,
Japan) when the cells reached confluence. The cells
formed a single thin layer after 2 weeks of plating, at
which time the UpCell dishes were placed at 25°C for
30 min to promote detachment of the cell sheet from the
bottom surface of the dish [11]. The cell sheet was then
removed from the dish using a cell shifter (CellSeed).
Three cell sheets were layered together to form a triple-
layered sheet, and this sheet was further cultured for
1 week in the UpCell dish.
Vitrification solutions
The vitrification solution developed for cryopreserv-
ing mammalian embryos [22,32] was used after slight
modifications.
Hepes (20 mM) buffered Tissue Culture Medium-199
(Nissui Pharmaceutical, Tokyo, Japan) supplemented with
20% calf serum (12133C; SAFC Biosciences, KS, USA) was
used as the basal solution. Dimethyl sulfoxide (DMSO) and
ethylene glycol (EG) were used as permeable CPAs. Sucrose
was used as a non-permeable CPA for all vitrification
experiments. In some experimental groups, carboxylated
poly-L-lysine (COOH-PLL) [33] was also added as a
supplemental non-permeable CPA.
An equilibration solution (ES) consisting of 10% (v/v)
DMSO and 10% (v/v) EG in the basal solution and a
vitrification solution (VS) containing 20% (v/v) DMSO,
20% (v/v) EG, and 0.5 M sucrose were prepared. The effect
of supplementation of the VS with 10% (w/v) COOH-PLL
was examined in some of the experimental groups. A
rewarming solution (RS) and a dilution solution (DS)
containing 1 M and 0.5 M sucrose, respectively, were
prepared and the basal solution was used as the washing
solution (WS).
The VS was used at ice temperature (on crushed ice),
and pre-warmed RS at 38°C was used to devitrify (rewarm)




The development of the coating method for the chondro-
cyte sheets was guided by the MVC concept [31], which
has been shown to be effective for the vitrification of
mammalian embryos. The method used here involves
vitrification of a cell sheet; this is achieved by treating a
cell sheet with ES and VS and then applying a thin coat
of VS containing permeable and non-permeable CPAs.
Maehara et al. BMC Biotechnology 2013, 13:58 Page 3 of 9
http://www.biomedcentral.com/1472-6750/13/58This technique enables vitrification of the cell sheet
with the minimum amount of vitrification solution
(Figure 1).
First, a triple-layered cell sheet was peeled from the
UpCell surface using a cell shifter and forceps, and
immersed in 5 ml of ES in a 60 mm dish (Iwaki 3010–060,
AGC Techno Glass, Shizuoka, Japan) for 5 min for pre-
equilibration. Then, the cell sheet was transferred to the
same solution in a fresh dish for 20 min (equilibration).
After equilibration, the cell sheet was transferred to VS
using forceps for 5 min (VS pre-treatment), and then
transferred to fresh VS in another dish for 15 min for
dehydration and the permeation of the permeable CPAs.
VS containing COOH-PLL and unmodified VS were
compared. After VS treatment, the cell sheet was carefully
placed on a stainless steel mesh (30 mm) using forceps
(Figure 2A). The cell sheet on the mesh was held 1 cm
above the surface of liquid nitrogen (LN) in a 1 L Styrofoam
bath and was vitrified by a 20 min exposure to the LN
vapor (−140°C) (Figure 2B). We observed that vitrification
of the cell sheet was completed within the first 5 min
(Figure 2C). The use of LN vapor was adopted after
preliminary tests demonstrated that the cell sheet fractured
when it was directly immersed in LN.
To rewarm a vitrified sheet, the mesh holding the
sheet was placed directly onto an electric heating plate
(HP-4530; ASONE Corporation, Osaka, Japan) at 38°C
for 90 sec (Figure 2D). After the sheet had completely
thawed, the mesh holding the sheet was slowly placed
into 10 ml of RS in a 60 mm dish and was gently removed
from the mesh using forceps (Figure 2E). At this stage, the
recovered sheet was checked for cracks. The CPAs wereFigure 1 The minimum volume cooling concept applied to
vitrification of an embryo and a cell sheet. A: The protocol of
embryo vitrification using the minimum volume cooling (MVC)
concept; the embryo is vitrified in a minimum volume of vitrification
solution on a plastic or metal plate with high thermal conductivity
[22,32]. B: For cryopreservation of triple-layered rabbit chondrocyte
sheets, we developed a coating method in which the cultured cell
sheet is thinly coated with a viscous vitrification solution containing
permeable and non-permeable cryoprotectants. This enables the cell
sheet to be vitrified in a minimum amount of vitrification solution in
accordance with the MVC concept.diluted and removed in a stepwise manner. Briefly, the cell
sheet was held in RS for 1 min and then transferred into
5 ml of DS using forceps for 3 min. Then, the cell sheet
was transferred twice into 5 ml of WS. The cell sheet
was gently shaken several times in each solution to help
diffusion of the CPAs.
Envelope method
A cell sheet pre-treated with ES and VS as described
above in the coating method, was placed onto a 5 × 10 cm
rectangular piece of polyvinylidene chloride kitchen wrap
(Kureha Corporation, Tokyo, Japan) using forceps. Then,
the wrapping film was folded to enclose the cell sheet
(Figure 2F). The wrapped sheet was held 1 cm above
the surface of LN and vitrified by exposure to the vapor
for 20 min (Figure 2G). Vitrification of the cell sheet
was observed within the first 5 min (Figure 2H). As the
presence of COOH-PLL in the VS was found to be essential
for maintaining the structure of the vitrified sheet in
the development of the coating method described above,
VS containing COOH-PLL was used for the envelope
method.
To rewarm the vitrified sheet, the cell sheet envelope
was placed directly onto a heating plate at 38°C for
90 sec (Figure 2I). When the sheet had completely
thawed, the wrapping film was slowly opened and the
sheet was transferred into RS using forceps (Figure 2J).
The recovered sheet was checked for cracks, and the
CPAs were diluted, removed, and washed as described
above for the coating method.
Dish method
In order to evaluate the effect of VS volume on cell
sheet vitrification, a sheet was immersed in 2 ml of VS,
a considerably larger volume than used in the coating or
envelope methods.
A preliminary study revealed the formation of many
cracks and ice crystals when the vitrification/rewarming
procedure was performed using 2 ml of VS in a 35 mm
plastic dish (Additional file 1: Figure S1A). However, ice
crystal and crack formation was significantly reduced
when the VS contained 10% COOH-PLL (Additional file 1:
Figure S1B). Therefore, the dish method was performed
using VS containing COOH-PLL.
A cell sheet was pretreated with ES and VS in the
same manner as in the coating and envelope methods,
placed in 2 ml of VS in a 35 mm dish (Nunc 150318,
Thermo Fisher Scientific, Kanagawa, Japan) for 15 min
for further CPA permeation and dehydration (Figure 2K).
The dish was held 1 cm above the surface of LN for
20 min (Figure 2L) to induce solidification of the VS
containing the sheet (Figure 2M).
To rewarm the vitrified sheet, the dish was allowed to
stand for 3 min on a heating plate at 38°C (Figure 2N).
Figure 2 Vitrification and rewarming methods for triple-layered rabbit chondrocyte sheets. (A-E) Coating method. A cell sheet treated
with ES and VS is placed on a stainless mesh using forceps (A) and exposed to liquid nitrogen (LN) vapor for vitrification (B). (C) A cell sheet
vitrified on mesh. Note the transparency of the vitrified sheet. For rewarming, the vitrified sheet on a mesh device is placed on a heating plate
for thawing (D) and then transferred to RS using forceps (E). (F-J) Wrapping film method. An ES- and VS-treated cell sheet was wrapped in an
envelope of polyvinylidene chloride film (F) and exposed to LN vapor for vitrification (G). (H) A cell sheet vitrified in wrapping film. Note that the
cell sheet is transparent when it solidifies. For rewarming, the sheet vitrified in the wrapping film is placed on a heating plate (I), followed by
transfer into RS (J). (K-O) Dish method. A cell sheet pretreated with ES and VS is placed in 2 ml VS (K) and exposed to LN vapor for vitrification
(L). (M) A cell sheet solidified with VS in a dish. Note the transparency of the vitrified solution and the lack of any cracks. (N) A dish containing a
cell sheet on a heating plate for rewarming. The opacity of the solution indicates that ice crystals have formed during the warming process. The
thawed cell sheet is then transferred into RS using forceps (O).
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sheet was transferred into RS using forceps (Figure 2O)
and checked for visible damage (cracks). The CPAs were
diluted, removed, and washed in the same manner as in
the coating method.
Survival of the cells in the vitrified cell sheet
A vitrified cell sheet recovered after rewarming, rehydration
and removal of CPAs was transferred into Dulbecco’s
phosphate-buffered saline (D-PBS; 10 ml) for washing.
The cell sheet was cut into 1–2 mm2 pieces with ophthal-
mic scissors, and the pieces were incubated in RPMI-1640
medium containing 2 mg/ml collagenase II (17101; GIBCO)
at 37°C for 40–50 min to isolate the cells. The suspension
of isolated cells was centrifuged at 1,000 rpm for 5 min,
and the precipitated cells were resuspended in RPMI-1640
medium (22400; GIBCO) and their viability was determined
after trypan blue staining (viability (%) = live cells/live and
dead cells × 100).Electron microscopy
Triple-layered chondrocyte sheets were soaked in 0.1 mol/l
D-PBS containing 2% glutaraldehyde for 2 h, then fixed in
2% osmium tetroxide solution for 1 h, and then dehydrated
through an ethanol series (50, 70, 80, 90, 95, and 100%).
Next, the ethanol was replaced by 100% tert-butyl alcohol,
and the samples were dried using freeze dryer (ES-2030;
Hitachi High-Technologies Corporation, Tokyo, Japan).
The dried specimens were sputter-coated with osmium
and affixed to an adhesive interface for observation with a
scanning electron microscope (JSM-6700 F; JEOL, Tokyo,
Japan). The top surfaces of the cell sheets were observed
at magnifications ranging from × 300 to × 2,000.
Histological examination and immunohistochemical
staining
Triple-layered cell sheets were harvested after culture
or cryopreservation and fixed in 4% paraformaldehyde
solution for 1 week. The specimens were embedded in
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glass slides. After deparaffinization and rehydration, the
sections were stained for proteoglycan with 0.1% Safranin-O
or immunostained with type II collagen antibody. For
immunohistochemistry, the slides were incubated with a
diluted primary anti-human type II collagen antibody
(F-57: Daiichi Fine Chemical, Toyama, Japan) for 16 h at
4°C, followed by incubation with the EnVision +Mouse/
HRP secondary antibody (K4000: DAKO, Glostrup,
Denmark) for 1 h at room temperature. Finally, the sec-
tions were stained with diaminobenzidine (K3466: DAKO)
and counterstained with hematoxylin. Coverslips were
mounted onto the slides and sealed with nail polish.
The slides were then examined under a microscope
and images were captured (Biozero BZ-8000, KEYENCE,
Osaka, Japan).Statistical analysis
Statistical analyses were performed using IBM SPSS
Statistics 20.0 software (IBM Corporation, NY, USA).
The proportional data were subjected to arcsine trans-
formation and evaluated by one-way analysis of vari-
ance (ANOVA) followed by multiple comparisons
using Tukey’s test. The level of significance was set at
p values < 0.05.Results and discussion
Maintenance of cell sheet structure and cell viability after
vitrification
Ten cell sheets were vitrified using the coating method
in the presence of 10% COOH-PLL (Table 1). After re-
warming, all the recovered sheets (100%) showed no
visible damage and had same appearance as non-vitrified
cell sheets (Figure 3A, B). Eight sheets were vitrified using
the coating method in the absence of COOH-PLL (Table 1);
only one of the recovered sheets (12.5%) did not have
visible damage, all of the remainder exhibited cracks
(Figure 3C). Cell viability in the vitrified cell sheets did
not differ between protocols with or without COOH-PLL
(92.1% vs. 91.9%); the rates of cell viability were compar-
able to that of the non-vitrified control (94.6%).Table 1 Structural maintenance and cell viability after vitrific







a-cValues with different superscript differ significantly (p < 0.05).
*VS: Vitrification Solution.These results clearly showed that vitrification by the
coating method in the presence of COOH-PLL as a sup-
plemental non-permeable CPA was capable of preserving
the membranous structure of the cell sheet with a high
survival rate for the constituent cells. To the best of
our knowledge, our results represent the first successful
vitrification of cell sheets grown in temperature-responsive
dishes. In this study, we vitrified cell sheets in LN vapor
rather than by direct immersion in the LN. This also had a
critical influence on the maintenance of the membranous
structure of the cell sheet during vitrification. In preliminary
experiments, all of the cell sheets cracked, even in the
presence of COOH-PLL, when they were vitrified by direct
immersion in LN. Possibly, the direct immersion approach
might have had a more drastic impact on membrane
integrity than the vapor and, thereby, impaired cell sheet
structure.
Since the coating method proved successful for vitrifi-
cation of cell sheets, we examined whether cell sheets
enveloped in a thin film could also be vitrified successfully.
Seven cell sheets were placed into film envelopes, vitrified
and rewarmed (Table 1). All the sheets (100%) were
recovered without visible damage (Figure 3D). However,
cell viability (86.8%) was slightly lower compared to that
in the coating method (p < 0.05).
For use in clinical applications, it would be preferable
if vitrified cell sheets could be stored and distributed in
hygienic coverings. Our results demonstrated that a cell
sheet enveloped in a thin film with a minimum volume
of VS could be successfully vitrified. However, wrapping
a cell sheet with a film might influence the optimal cooling
and rewarming rates during vitrification and rewarming
processes. As cooling and warming rates have a crucial
influence on the viability of vitrified cells [34,35], it will
be important to identify robust film materials that have
high thermal conductivity and are protective against inva-
sive pathogens, as well as improving cooling and rewarming
methods.
We also examined the influence of the volume of vit-
rification solution on the morphology and survival of
cell sheets. Seven cell sheets were vitrified using the dish
method (Table 1) that involves a substantially greateration of triple-layered rabbit chondrocyte sheets
No. of cell sheets recovered without
racture / No. of cell sheets examined (%)
Cell viability
(mean ± SEM)
8/8 (100) 94.6 ± 0.5a
10/10 (100) 92.1 ± 0.9a
1/8 (12.5) 91.9 ± 0.7a
7/7 (100) 86.8 ± 0.7b
7/7 (100) 77.6 ± 3.15c
Figure 3 The macro- and microstructures of triple-layered rabbit chondrocyte sheets after vitrification. A-E: Morphological appearance of
chondrocyte sheets after vitrification and rewarming. A1-E2: Scanning electron microscopic images of the surfaces of cell sheets recovered after
vitrification and rewarming. A1-E1: ×300, Scale bar = 50 μm; A2-E2: ×2,000, Scale bar = 10 μm. The surfaces (A1-E2) are irregular, featuring
pavement-like cell populations (arrowheads in A1-E1 indicate representative three cells) and well-developed extracellular matrices with a dense
fibrous structure (*). The microstructures of cell sheets vitrified by any of the methods described in this report were similar to those of the
non-vitrified control sample.
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containing COOH-PLL was used because a preliminary
experiment revealed that its presence was essential to
ensure crack-free vitrification using the dish method
(Additional file 1: Figure S1). All of the 7 sheets (100%)
that were vitrified were recovered without any cracks
(Figure 3E). However, cell viability after vitrification was
77.6%, which was significantly lower than that observed
following vitrification with the coating or envelope methods
(p < 0.05).
High levels of viability can be achieved by minimizing the
volume of the solution used for vitrification of mammalian
embryos [31]. In contrast, the vitreous state becomes
unstable when larger solution volumes are employed:
more cracks tend to occur during the solidification of the
solution and more ice crystals form upon rewarming. Our
results demonstrated that addition of COOH-PLL as
a non-permeable CPA was effective in stabilizing the
vitrified state of the solution. However, even when the
VS contained COOH-PLL, cell viability was reduced
slightly with the dish method. The decrease might be
attributed to the slower cooling and warming rates and/or
ice crystal formation during rewarming. We observed
that the VS appeared opaque for a moment during therewarming process in the dish method, suggesting the
occurrence of ice crystal formation.
Scanning electron microscopic images of the surface of
vitrified cell sheets
The microstructures of the cell sheets vitrified in the four
experimental groups were compared to those of the
non-vitrified sample (Figure 3). Although slight differences
were observed among individual sheets, overall, the cell
sheets retained their basic structure of pavement-like cells
(Figure 3A1-E2) distributed within well-developed extra-
cellular matrices (Figure 3A2-E2). The sheet surfaces were
irregular, featuring well-developed extracellular matrices
with dense fibrous structures (Figure 3A1-E2).
The microstructures of cell sheets were maintained in
the vitrified samples of all the experimental groups under
the same conditions as the non-vitrified control groups.
The sheets that developed cracks during vitrification with
the coating method in the absence of COOH-PLL
showed no microstructural abnormalities (Figure 3C1,
C2), suggesting that the fracturing of the sheet structure
did not affect the microstructure. The sheets vitrified by
the envelope method (Figure 3D1, D2) and the dish method
(Figure 3E1, E2), where cell viabilities were slightly
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These results indicate that the microstructure of the
vitrified cell sheet, including the extracellular matrix, were
well maintained even after vitrification and rewarming
under suboptimal conditions.
Histological and immunohistochemical examination of
vitrified cell sheets
Cell sheets vitrified with the coating and envelope methods
in the presence of COOH-PLL were histochemically and
immunohistochemically examined to investigate the
distribution of the major components of cartilage, i.e.
proteoglycan and type II collagen. In the non-vitrified
control (Figure 4A) and the vitrified cell sheet, strong
Safranin-O staining was exhibited (coating method:
Figure 4C, envelope method: Figure 4E). These results
showed that acidic proteoglycan were, in general, densely
and evenly distributed throughout the chondrocyte sheet
and this distribution pattern was maintained after vitrifica-
tion in the coating and envelope methods.
The vitrified samples also exhibited large amounts of
type II collagen (Figure 4D, F) in a similar manner as in
the non-vitrified control (Figure 4B). Overall, these
data showed that the extracellular matrix of the vitrifiedFigure 4 Histological and immunohistochemical examination of triple
(A, C, E) and type II collagen (B, D, F) on cross-sections of cell sheets recov
sheet exhibiting large amounts of proteoglycan and type II collagen in the
using VS containing COOH-PLL; the sheet exhibits a normal extracellular m
extracellular matrix exhibits no difference to samples from control and coacell sheets had been maintained in both the coating and
envelope methods.
Significance of maintaining membranous structure in
chondrocyte sheet cryopreservation
In the conventional slow-freezing method, cultured cell
sheets are frozen in the presence of a relatively low con-
centration of a CPA [21]. Thus, extra- and intracellular
ice crystal formation is inevitable during freezing, which
destroys the cell sheet structure and decreases cell viability
[21]. In contrast, with the vitrification method, a solution
containing a high concentration of a CPA is rapidly cooled
to achieve the transition from the liquid phase to the solid
phase (amorphous) without ice crystal formation [36].
Therefore, cell sheets could be sealed in a glassy state that
maintained their macro- and microstructures and also
allowed high cell viability.
In cell sheet therapy, cytokines and growth factors
produced by the cell sheet play an important role in
healing damaged tissues [11,19,20]. We found that the
formation of a chondrocyte sheet structure enhanced
transforming growth factor-β secretion from the cells
[37], which implies that maintaining the membranous
structure after cryopreservation is a prerequisite for-layered rabbit chondrocyte sheets. Staining for proteoglycan
ered after vitrification and rewarming. A, B: Non-vitrified control cell
extracellular matrix. C, D: Cell sheet vitrified with the coating method
atrix. E, F: Cell sheets vitrified by the envelope method. The
ting method groups. (Scale bar = 100 μm).
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both the maintenance of sheet structures and of cell
viability after vitrification. Thus, our study provides
the first demonstration that cryopreservation of cultured
chondrocyte sheets with a fragile membranous structure
can be achieved using a vitrification method developed on
the basis of the MVC concept. Biochemical functions such
as cytokine production by the vitrified chondrocyte sheets
has yet to be analyzed. Additionally, transplantation exper-
iments using vitrified cell sheets are under consideration.
In our preliminary study, we could successfully vitrify
cell sheets with more fragile characteristics including
human chondrocyte sheets. It is, therefore, likely that the
vitrification method developed in the present study can be
applied to different types of cell sheet other than the triple
layered rabbit chondrocyte sheets. In application of the
vitrification technology to human therapies, toxicity of
CPAs to human cells needs to be verified.Conclusions
In this study, we demonstrate that the vitrification method
developed here facilitated the cryopreservation of a
chondrocyte sheet while maintaining its macro- and
microstructures and allowing a high rate of viability of
the constituent cells. The coating method, where the
cell sheet was vitrified with a minimum volume of VS
in the presence of COOH-PLL, effectively prevented
structural damage due to vitrification. Here, we propose
three basic principles essential to the cryopreservation
of chondrocyte sheets: (i) minimizing the volume of the
vitrification solution by using the coating method, (ii)
stabilizing the vitreous state via the addition of COOH-PLL
as a non-permeable CPA, and (iii) preventing the
occurrence of cracks in the vitrified solution by cooling
samples in LN vapor instead of direct immersion into
LN. The cryopreservation technology developed in this
study will play a pivotal role in clinical applications of cell
sheet-based therapies.Additional file
Additional file 1: Figure S1. Protective effect of COOH-PLL against
fracture of vitrified solution. COOH-PLL-free (A) and COOH-PLL-containing
(B) solutions in the process of rewarming after vitrification in liquid
nitrogen vapor. Note the occurrence of many cracks in the COOH-PLL-free
solution (A), while the COOH-PLL-containing solution is free of cracks (B).
The opacity of the solution in B indicates that ice crystals formed during
the warming process.Abbreviations
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